分析前血液样本不合格的原因及干预措施有效性分析  

Study of Pre-analysis Unqualified Blood Samples' Causes and Intervention Measure's Effectiveness

作　　者：胡智颖[1] 胡梅[1] 张曼[1] 

机构地区：[1]首都医科大学附属北京世纪坛医院医学检验科,北京100038

出　　处：《标记免疫分析与临床》2015年第12期1277-1279,共3页Labeled Immunoassays and Clinical Medicine

摘　　要：目的分析血液样本不合格的原因并观察干预措施的有效性,为分析前样本质量控制提供针对性建议。方法统计我院2013年11月至2014年6月病房不合格血液样本数量并进行原因分析;针对不同原因及重点高发科室采取干预措施,通过统计不合格样本发生率来分析干预措施的有效性。结果我院病房血液样本不合格的原因主要为技术问题、患者准备及责任问题,其中技术问题包括血液凝固、溶血、抽血量问题;不合格血液样本高发科室主要为重症监护病房、肿瘤外科病房以及呼吸内科病房;采取干预措施后,除抽血量问题外,不合格血液样本总体发生率及重点干预科室不合格样本发生率均有下降趋势。结论通过实施积极、有效的干预指导措施,可有效降低不合格样本的发生率。Objective To analyze the reasons of unqualified blood samples and observe the intervention measure＇ s effectiveness, in order to provide the targeted recommendations for the pre-analysis samples＇ quality control. Methods The data of unqualified inpatient blood samples collected from 2013 Nov to 2014 Jun was sorted by the type of reason and analyzed. The preventive and corrective actions were carried out and the effectiveness of the actions was analyzed by observed the trend of the data. Results The causes of unqualified blood samples were classified to technology problems, patient preparation and responsibility. The technology problems included blood coagulation, hemolysis and the problems of blood sample amount. The departments of hospital which have a higher incidence of unqualified blood sample mainly focused on the Intensive Care Unit, surgical oncology and Pneumology Department. By taking preventive and corrective actions, the incidence of total unqualified blood samples and key departments＇ qualified blood samples had been reduced obviously. Conclusion The incidence of total unqualified blood samples could be reduced by taking the positive and effective intervention measures.

关 键 词：分析前 不合格血液样本 原因分析 

分 类 号：R446.1[医药卫生—诊断学]